Keith Phillip Laby

Conor Medsystems LLC develops vascular drug delivery technologies. Its products include controlled vascular drug delivery technologies and novel stent that are used in the treatment of coronary artery disease and delivery of a broad spectrum of therapeutic agents. The company was founded by John F. Shanley in 1999 and is headquartered in Menlo Park, CA.

VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Claret Medical, Inc. develops a cerebral protection technology designed to protect patients from the risk of stroke during left heart procedures and vascular interventions. It focuses on addressing the problem of stroke during transcatheter aortic valve replacement (TAVR), a significant unmet clinical need. The company was founded by Farhad Khosravi and Randy Lashinski in 2009 and is headquartered in Santa Rosa, CA.

SoundBite Medical Solutions Inc. offers medical devices. It develops and commercializes proprietary shockwave device and generator technology. The company was founded by Steve Arless, Martin Brouillette, Louis-Philippe Riel and Steven Dion and is headquartered in Montreal, Canada.

415 Capital Management GmbH (415 Capital) is an independent venture capital firm founded in 2018 by Frank Gabriel Groenewegen, David P. Thompson and Frederik Justin Gabriel Groenewegen. The firm is headquartered in Oberhaching, Germany.

InnovHeart Srl is a holding company, which engages in the development of transcatheter mitral valve replacement (TMVR) systems for the treatment of patients with mitral valve disease. It also develops Saturn Prosthesis, Transapical, and Transeptal systems that are designed to be consistent with the anatomy of the mitral valve. The company was founded by Giovanni Righini and is headquartered in Milan, Italy.

Croivalve Ltd. develops medical device for treatment of tricuspid regurgitation. The company was founded by Lucy O'Keeffe and Martin Quinn in 2016 and is headquartered in Dublin, Ireland.

Vessl, Inc. engages in manufacturing soft drinks. It offers peach ginger black tea, pomegranate acai white tea, unsweetened black tea, citrus mint green tea, and recovery formula. The company was founded by Walter Apodaca and Don Park on February 10, 2014 and is headquartered in Tempe, AZ.

Protembis GmbH develops and manufactures medical devices for surgical heart procedures. Its device ProtEmbo is intended to protect patients from the risk of suffering a stroke during these procedures. The company was founded by Karl von Mangoldt and Conrad Rasmus in 2013 and is headquartered in Hamburg, Germany.